23andMe Holding (ME) said late Tuesday a special committee of its board has started exploring strategic alternatives, including a possible sale of the company or its assets, a business combination and a restructuring.
The special committee has retained Moelis & Co. and Goodwin Procter as advisers, the company said.
The company does not plan to disclose further updates on the process until it makes an agreement, it said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.